Improvement of cancer immunotherapy by combining molecular targeted therapy.

Improvement of cancer immunotherapy by combining molecular targeted therapy.

Item
http://www.wikidata.org/entity/Q41075854
Melanoma: oncogenic drivers and the immune systemDendritic cell-targeted approaches to modulate immune dysfunction in the tumor microenvironmentShenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltrationExpression of signal transducer and activator of transcription 3 and its phosphorylated form is significantly upregulated in patients with papillary thyroid cancer.Dendritic cell-based vaccines: clinical applications in breast cancer.Combination therapy for melanoma with BRAF/MEK inhibitor and immune checkpoint inhibitor: a mathematical model.Cancer immunotherapy and next-generation clinical immune assessment.Involvement of local renin-angiotensin system in immunosuppression of tumor microenvironment.Mechanism and Management of Cancer Chemotherapy-Induced Atherosclerosis
P2860

Improvement of cancer immunotherapy by combining molecular targeted therapy.

Item
http://www.wikidata.org/entity/Q41075854
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Improvement of cancer immunotherapy by combining molecular targeted therapy.
@en
type
label
Improvement of cancer immunotherapy by combining molecular targeted therapy.
@en
prefLabel
Improvement of cancer immunotherapy by combining molecular targeted therapy.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Improvement of cancer immunotherapy by combining molecular targeted therapy
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P921
P932